Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Decision Making on Radioactive Iodine Treatment for Papillary Thyroid Cancer

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Ontario Ministry of Health and Long Term Care
Canadian Institutes of Health Research (CIHR)
Information provided by (Responsible Party):
University Health Network, Toronto
ClinicalTrials.gov Identifier:
NCT01083550
First received: February 24, 2010
Last updated: September 23, 2015
Last verified: September 2015